TikTok's Crackdown on Ozempic Influencers Threatens Weight-Loss Drug Hype Machine [BNN Bloomberg (Canada)]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: BNN Bloomberg
from appearing on its app starting next month, according to a sweeping new set of community guidelines published on its website last week. The app has become ground zero for weight-loss drug content, as patients looking for more information about popular medications such as Novo Nordisk A/S's Wegovy and Eli Lilly & Co.'s Zepbound turn to social media for answers. According to the new rules, the app will no longer allow the marketing of weight-loss products and will specifically restrict minors from viewing or sharing content that shows, describes and promotes “potentially harmful” weight management behaviors, including using weight-loss medications. The rules extend to sharing so-called “before-and-after” photos used to show the physical effects of a weight-loss transformation. Creators, some who have racked up tens of thousands of followers posting content about drugs used to treat diabetes and obesity, say the broad set of restrictions will penalize a growing community keen to s
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- The FTC Cracks Down On Novo Nordisk's Ozempic [Seeking Alpha]Seeking Alpha
- Weight-loss drug competition heats up. Is Wegovy in trouble? [Yahoo! Finance]Yahoo! Finance
- Weight-loss drug competition heats up. Is Wegovy in trouble? [Yahoo! Finance Canada]Yahoo! Finance Canada
- Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide [CNBC]CNBC
- Amgen stock rallies 13% on GLP-1 weight-loss drug update [Seeking Alpha]Seeking Alpha
NVO
Earnings
- 5/2/24 - Beat
NVO
Sec Filings
- 5/2/24 - Form 6-K
- 5/1/24 - Form 6-K
- 4/26/24 - Form 6-K
- NVO's page on the SEC website